Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Thrombosis × enoxaparin sodium × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Venous Thromboembolism 1 Thrombosis 1 Thrombophilia 1 Thromboembolism 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Pulmonary Embolism 1 Multiple Myeloma 1 Lymphoma 1 Leukemia 1 Hematologic Neoplasms 1 Esophageal Neoplasms 1 Digestive System Diseases 1

Interventions

apixaban 5 Heparin, Low-Molecular-Weight 4 Enoxaparin 4 Dalteparin 4 Rivaroxaban 3 Blood Specimen Collection 3 Warfarin 2 Injections 2 Aspirin 2 Anticoagulants 2 salicylhydroxamic acid 1 palbociclib 1 fluorescein isothiocyanate-keyhole limpet hemocyanin 1 enoxaparin sodium 1 edoxaban 1 bemiparin 1 X-Rays 1 Ultrasonography 1 Tinzaparin 1 Technetium Tc 99m Sulfur Colloid 1 Standard of Care 1 Simvastatin 1 Radiotherapy, Conformal 1 Physical Therapy Modalities 1 Photons 1 Phlebotomy 1 Paclitaxel 1 Observation 1 Musculoskeletal Manipulations 1 Hydroxyurea 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06153394 2024-04-23

PRIORITY

Western University, Canada

Phase 3 Not yet recruiting

Digestive System Diseases, Thrombosis, Thrombophilia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡